CFDA Plans to Double Drug Review Staff: From 800 to 1,600

Published: Jan 12, 2018

January 11, 2018 -- According to an article in BioCentury, the CFDA plans to double its drug application reviewers from 800 presently to 1,600 by 2020. In 2015, the CFDA employed just 170 reviewers, meaning the agency will increase its reviewing staff by almost 10-fold over a six-year period. The news was disclosed by Ruyi He, MD, Chief Scientist of the CFDA and the Center for Drug Evaluation, who was speaking at the WuXi Global Forum in San Francisco earlier this week.

Back to news